AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jan 18, 2016
5262_dirs_2016-01-18_5d5e5ca7-846e-439e-ba68-97ad50287468.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1557M
GlaxoSmithKline PLC
18 January 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc ('GSK') was advised on 18 January 2016 that the following acquisitions of GSK Ordinary shares took place on 15 January 2016, at a price of 1377.50 pence per Ordinary share, following the re-investment of the dividend paid to shareholders on 14 January 2016, on shares held within an ISA:
| Director/PDMR | Number of Ordinary shares |
| Sir Andrew Witty | 152 |
| Mr D S Redfern | 23 |
| Mrs V A Whyte | 19 |
| Connected Person | Number of Ordinary shares |
| Lady C Witty (Connected Person of Sir Andrew Witty) | 39 |
V A Whyte
Company Secretary
18 January 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBVLFFQFFZBBE